Last week, amid a flurry of election policies and debates, a striking report found that cancer survival in England currently lags up to 25 years behind European countries like Sweden, Norway and Denmark. From bowel cancer to breast diagnoses, England is firmly lagging behind our Scandinavian neighbours. What’s to blame?
Why aren’t major parties discussing how this decline could be reversed in their manifestos?
The revelation by Macmillan Cancer Support is the legacy of many years of underfunding, resulting in delays to diagnosis and treatment.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in